Visikol, a biotechnology spinout from Rutgers University, has raised $500,000 from Foundation Venture Capital Group.
Visikol has created a biological clearing agent, a chemical that renders biological tissue transparent. The resulting changes enables researchers to see within a biological specimen and visualise internal structures.
The technology is based on research by Tom Villani, now the chief scientific officer of Visikol, who developed it when he was a graduate student at Rutgers. He was assisted by his professors James Simon and Adolfina Koroch.
Michael Johnson, chief executive officer for Visikol, said: “This biological clearing agent is transformative in its ability to easily, effectively and quickly clear animal and plant tissue.
“Because it can clear whole tissue, it allows for 3D visualisation of tissue instead of the traditional slicing based 2D visualisation approach.”
